0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-34M23
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-34M23
Report
September 2021
113 Pages
QYResearch
Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
 
Market Analysis and Insights: Global Rabies Vaccine Market

In 2020, the global Rabies Vaccine market size was US$ 877 million and it is expected to reach US$ 1178 million by the end of 2027, with a CAGR of 4.0% during 2021-2027.

Global Rabies Vaccine Scope and Market Size
Rabies Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Rabies Vaccine market is segmented into

  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Others

Segment by Application, the Rabies Vaccine market is segmented into

  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Regional and Country-level Analysis:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
 
Competitive Landscape and Rabies Vaccine Market Share Analysis
Rabies Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Rabies Vaccine product introduction, recent developments, Rabies Vaccine sales by region, type, application and by sales channel.
 
The major companies include:
  • GSK (Novartis)
  • Sanofi-Pasteur
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen
1 Study Coverage
1.1 Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine Market Size Estimates and Forecasts
2.1.1 Global Rabies Vaccine Revenue 2016-2027
2.1.2 Global Rabies Vaccine Sales 2016-2027
2.2 Rabies Vaccine Market Size by Region: 2021 Versus 2027
2.3 Rabies Vaccine Sales by Region (2016-2027)
2.3.1 Global Rabies Vaccine Sales by Region: 2016-2021
2.3.2 Global Rabies Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Rabies Vaccine Sales Market Share by Region (2016-2027)
2.4 Rabies Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Rabies Vaccine Revenue by Region: 2016-2021
2.4.2 Global Rabies Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Rabies Vaccine Revenue Market Share by Region (2016-2027)
3 Global Rabies Vaccine by Manufacturers
3.1 Global Top Rabies Vaccine Manufacturers by Sales
3.1.1 Global Rabies Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Rabies Vaccine Manufacturers by Revenue
3.2.1 Global Rabies Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Rabies Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Rabies Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Rabies Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Rabies Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Rabies Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Rabies Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK (Novartis)
4.1.1 GSK (Novartis) Corporation Information
4.1.2 GSK (Novartis) Description, Business Overview
4.1.3 GSK (Novartis) Rabies Vaccine Products Offered
4.1.4 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 GSK (Novartis) Rabies Vaccine Revenue by Product
4.1.6 GSK (Novartis) Rabies Vaccine Revenue by Application
4.1.7 GSK (Novartis) Rabies Vaccine Revenue by Geographic Area
4.1.8 GSK (Novartis) Rabies Vaccine Revenue by Sales Channel
4.1.9 GSK (Novartis) Recent Development
4.2 Sanofi-Pasteur
4.2.1 Sanofi-Pasteur Corporation Information
4.2.2 Sanofi-Pasteur Description, Business Overview
4.2.3 Sanofi-Pasteur Rabies Vaccine Products Offered
4.2.4 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Sanofi-Pasteur Rabies Vaccine Revenue by Product
4.2.6 Sanofi-Pasteur Rabies Vaccine Revenue by Application
4.2.7 Sanofi-Pasteur Rabies Vaccine Revenue by Geographic Area
4.2.8 Sanofi-Pasteur Rabies Vaccine Revenue by Sales Channel
4.2.9 Sanofi-Pasteur Recent Development
4.3 Chengda
4.3.1 Chengda Corporation Information
4.3.2 Chengda Description, Business Overview
4.3.3 Chengda Rabies Vaccine Products Offered
4.3.4 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Chengda Rabies Vaccine Revenue by Product
4.3.6 Chengda Rabies Vaccine Revenue by Application
4.3.7 Chengda Rabies Vaccine Revenue by Geographic Area
4.3.8 Chengda Rabies Vaccine Revenue by Sales Channel
4.3.9 Chengda Recent Development
4.4 Yisheng
4.4.1 Yisheng Corporation Information
4.4.2 Yisheng Description, Business Overview
4.4.3 Yisheng Rabies Vaccine Products Offered
4.4.4 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Yisheng Rabies Vaccine Revenue by Product
4.4.6 Yisheng Rabies Vaccine Revenue by Application
4.4.7 Yisheng Rabies Vaccine Revenue by Geographic Area
4.4.8 Yisheng Rabies Vaccine Revenue by Sales Channel
4.4.9 Yisheng Recent Development
4.5 Prcmise
4.5.1 Prcmise Corporation Information
4.5.2 Prcmise Description, Business Overview
4.5.3 Prcmise Rabies Vaccine Products Offered
4.5.4 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Prcmise Rabies Vaccine Revenue by Product
4.5.6 Prcmise Rabies Vaccine Revenue by Application
4.5.7 Prcmise Rabies Vaccine Revenue by Geographic Area
4.5.8 Prcmise Rabies Vaccine Revenue by Sales Channel
4.5.9 Prcmise Recent Development
4.6 VACN
4.6.1 VACN Corporation Information
4.6.2 VACN Description, Business Overview
4.6.3 VACN Rabies Vaccine Products Offered
4.6.4 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 VACN Rabies Vaccine Revenue by Product
4.6.6 VACN Rabies Vaccine Revenue by Application
4.6.7 VACN Rabies Vaccine Revenue by Geographic Area
4.6.8 VACN Recent Development
4.7 Changsheng
4.7.1 Changsheng Corporation Information
4.7.2 Changsheng Description, Business Overview
4.7.3 Changsheng Rabies Vaccine Products Offered
4.7.4 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Changsheng Rabies Vaccine Revenue by Product
4.7.6 Changsheng Rabies Vaccine Revenue by Application
4.7.7 Changsheng Rabies Vaccine Revenue by Geographic Area
4.7.8 Changsheng Recent Development
4.8 BCHT
4.8.1 BCHT Corporation Information
4.8.2 BCHT Description, Business Overview
4.8.3 BCHT Rabies Vaccine Products Offered
4.8.4 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.8.5 BCHT Rabies Vaccine Revenue by Product
4.8.6 BCHT Rabies Vaccine Revenue by Application
4.8.7 BCHT Rabies Vaccine Revenue by Geographic Area
4.8.8 BCHT Recent Development
4.9 Hissen
4.9.1 Hissen Corporation Information
4.9.2 Hissen Description, Business Overview
4.9.3 Hissen Rabies Vaccine Products Offered
4.9.4 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Hissen Rabies Vaccine Revenue by Product
4.9.6 Hissen Rabies Vaccine Revenue by Application
4.9.7 Hissen Rabies Vaccine Revenue by Geographic Area
4.9.8 Hissen Recent Development
5 Breakdown Data by Type
5.1 Global Rabies Vaccine Sales by Type (2016-2027)
5.1.1 Global Rabies Vaccine Sales by Type (2016-2021)
5.1.2 Global Rabies Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Rabies Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Rabies Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Rabies Vaccine Revenue by Type (2016-2021)
5.2.2 Global Rabies Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Rabies Vaccine Revenue Market Share by Type (2016-2027)
5.3 Rabies Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Rabies Vaccine Sales by Application (2016-2027)
6.1.1 Global Rabies Vaccine Sales by Application (2016-2021)
6.1.2 Global Rabies Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Rabies Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Rabies Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Rabies Vaccine Revenue by Application (2016-2021)
6.2.2 Global Rabies Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Rabies Vaccine Revenue Market Share by Application (2016-2027)
6.3 Rabies Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Rabies Vaccine Market Size YoY Growth 2016-2027
7.2 North America Rabies Vaccine Market Facts & Figures by Country
7.2.1 North America Rabies Vaccine Sales by Country (2016-2027)
7.2.2 North America Rabies Vaccine Revenue by Country (2016-2027)
7.3 North America Rabies Vaccine Sales by Type
7.4 North America Rabies Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Rabies Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Rabies Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Rabies Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Rabies Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Rabies Vaccine Sales by Type
8.4 Asia-Pacific Rabies Vaccine Sales by Application
9 Europe
9.1 Europe Rabies Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Rabies Vaccine Market Facts & Figures by Country
9.2.1 Europe Rabies Vaccine Sales by Country (2016-2027)
9.2.2 Europe Rabies Vaccine Revenue by Country (2016-2027)
9.3 Europe Rabies Vaccine Sales by Type
9.4 Europe Rabies Vaccine Sales by Application
10 Latin America
10.1 Latin America Rabies Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Rabies Vaccine Market Facts & Figures by Country
10.2.1 Latin America Rabies Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Rabies Vaccine Revenue by Country (2016-2027)
10.3 Latin America Rabies Vaccine Sales by Type
10.4 Latin America Rabies Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Rabies Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Rabies Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Rabies Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Rabies Vaccine Sales by Type
11.4 Middle East and Africa Rabies Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Rabies Vaccine Supply Chain Analysis
12.2 Rabies Vaccine Key Raw Materials and Upstream Suppliers
12.3 Rabies Vaccine Clients Analysis
12.4 Rabies Vaccine Sales Channel and Sales Model Analysis
12.4.1 Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Rabies Vaccine Distributors
13 Market Dynamics
13.1 Rabies Vaccine Market Drivers
13.2 Rabies Vaccine Market Opportunities
13.3 Rabies Vaccine Market Challenges
13.4 Rabies Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Rabies Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Vero Cell Rabies Vaccine
    Table 3. Major Manufacturers of BHK
    Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine
    Table 5. Major Manufacturers of Others
    Table 6. Global Rabies Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 7. Global Rabies Vaccine Market Size by Region (US$ Million): 2021 VS 2027
    Table 8. Global Rabies Vaccine Sales by Region (2016-2021) & (K Units)
    Table 9. Global Rabies Vaccine Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Rabies Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Rabies Vaccine Sales by Manufacturer (2016-2021) & (K Units)
    Table 13. Global Rabies Vaccine Sales Share by Manufacturer (2016-2021)
    Table 14. Rabies Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 15. Rabies Vaccine Revenue Share by Manufacturer (2016-2021)
    Table 16. Key Manufacturers Rabies Vaccine Price (2016-2021) & (USD/Unit)
    Table 17. Ranking of Global Top Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2020)
    Table 20. Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Rabies Vaccine Product Type
    Table 22. Date of International Manufacturers Enter into Rabies Vaccine Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. GSK (Novartis) Corporation Information
    Table 25. GSK (Novartis) Description and Business Overview
    Table 26. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 27. GSK (Novartis) Rabies Vaccine Product
    Table 28. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 29. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 30. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 31. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 32. GSK (Novartis) Recent Development
    Table 33. Sanofi-Pasteur Corporation Information
    Table 34. Sanofi-Pasteur Description and Business Overview
    Table 35. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 36. Sanofi-Pasteur Rabies Vaccine Product
    Table 37. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 38. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 39. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 40. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 41. Sanofi-Pasteur Recent Development
    Table 42. Chengda Corporation Information
    Table 43. Chengda Description and Business Overview
    Table 44. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 45. Chengda Rabies Vaccine Product
    Table 46. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 47. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 48. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 49. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 50. Chengda Recent Development
    Table 51. Yisheng Corporation Information
    Table 52. Yisheng Description and Business Overview
    Table 53. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 54. Yisheng Rabies Vaccine Product
    Table 55. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 56. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 57. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 58. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 59. Yisheng Recent Development
    Table 60. Prcmise Corporation Information
    Table 61. Prcmise Description and Business Overview
    Table 62. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 63. Prcmise Rabies Vaccine Product
    Table 64. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 65. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 66. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 67. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 68. Prcmise Recent Development
    Table 69. VACN Corporation Information
    Table 70. VACN Description and Business Overview
    Table 71. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 72. VACN Rabies Vaccine Product
    Table 73. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 74. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 75. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 76. VACN Recent Development
    Table 77. Changsheng Corporation Information
    Table 78. Changsheng Description and Business Overview
    Table 79. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 80. Changsheng Rabies Vaccine Product
    Table 81. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 82. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 83. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 84. Changsheng Recent Development
    Table 85. BCHT Corporation Information
    Table 86. BCHT Description and Business Overview
    Table 87. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 88. BCHT Rabies Vaccine Product
    Table 89. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 90. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 91. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 92. BCHT Recent Development
    Table 93. Hissen Corporation Information
    Table 94. Hissen Description and Business Overview
    Table 95. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 96. Hissen Rabies Vaccine Product
    Table 97. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Product
    Table 98. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Application
    Table 99. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 100. Hissen Recent Development
    Table 101. Global Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 102. Global Rabies Vaccine Sales Forecast by Type (2022-2027) & (K Units)
    Table 103. Global Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 104. Global Rabies Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 105. Global Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 106. Global Rabies Vaccine Sales Forecast by Application (2022-2027) & (K Units)
    Table 107. Global Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 108. Global Rabies Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 109. North America Rabies Vaccine Sales by Country (2016-2021) & (K Units)
    Table 110. North America Rabies Vaccine Sales by Country (2022-2027) & (K Units)
    Table 111. North America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 112. North America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 113. North America Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 114. North America Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 115. Asia-Pacific Rabies Vaccine Sales by Region (2016-2021) & (K Units)
    Table 116. Asia-Pacific Rabies Vaccine Sales by Region (2022-2027) & (K Units)
    Table 117. Asia-Pacific Rabies Vaccine Revenue by Region (2016-2027) & (US$ Million)
    Table 118. Asia-Pacific Rabies Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 119. Asia-Pacific Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 120. Asia-Pacific Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 121. Europe Rabies Vaccine Sales by Country (2016-2021) & (K Units)
    Table 122. Europe Rabies Vaccine Sales by Country (2022-2027) & (K Units)
    Table 123. Europe Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 124. Europe Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 125. Europe Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 126. Europe Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 127. Latin America Rabies Vaccine Sales by Country (2016-2021) & (K Units)
    Table 128. Latin America Rabies Vaccine Sales by Country (2022-2027) & (K Units)
    Table 129. Latin America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 130. Latin America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 131. Latin America Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 132. Latin America Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 133. Middle East and Africa Rabies Vaccine Sales by Country (2016-2021) & (K Units)
    Table 134. Middle East and Africa Rabies Vaccine Sales by Country (2022-2027) & (K Units)
    Table 135. Middle East and Africa Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 136. Middle East and Africa Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 137. Middle East and Africa Rabies Vaccine Sales by Type (2016-2021) & (K Units)
    Table 138. Middle East and Africa Rabies Vaccine Sales by Application (2016-2021) & (K Units)
    Table 139. Rabies Vaccine Key Raw Materials, Industry Status and Trend
    Table 140. Rabies Vaccine Key Raw Materials and Upstream Suppliers
    Table 141. Rabies Vaccine Clients Status and Trend
    Table 142. Rabies Vaccine Typical Clients
    Table 143. Rabies Vaccine Distributors
    Table 144. Key Drivers: Impact Analysis (2022-2027)
    Table 145. Rabies Vaccine Market Drivers
    Table 146. Rabies Vaccine Market Opportunities
    Table 147. Rabies Vaccine Market Challenges
    Table 148. Rabies Vaccine Market Restraints
    Table 149. Rabies Vaccine Porter’s Five Forces Analysis
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rabies Vaccine Product Picture
    Figure 2. Global Rabies Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Vero Cell Rabies Vaccine Product Picture
    Figure 4. BHK Product Picture
    Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Rabies Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 8. Pre-exposure Prophylaxis Examples
    Figure 9. Post-exposure Prophylaxis Examples
    Figure 10. Rabies Vaccine Report Years Considered
    Figure 11. Global Rabies Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Rabies Vaccine Market Size 2016-2027 (US$ Million)
    Figure 13. Global Rabies Vaccine Sales 2016-2027 (K Units)
    Figure 14. Global Rabies Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Rabies Vaccine Sales Market Share Forecast by Region (2016-2027)
    Figure 16. Global Rabies Vaccine Revenue Market Share by Region (2016-2027)
    Figure 17. Global Rabies Vaccine Sales Share by Manufacturer in 2020
    Figure 18. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 19. Global Rabies Vaccine Sales Market Share Forecast by Type (2016-2027)
    Figure 20. Global Rabies Vaccine Revenue Market Share Forecast by Type (2016-2027)
    Figure 21. Rabies Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 22. Global Rabies Vaccine Sales Market Share Forecast by Application (2016-2027)
    Figure 23. Global Rabies Vaccine Revenue Market Share Forecast by Application (2016-2027)
    Figure 24. Rabies Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 25. North America Rabies Vaccine Revenue 2016-2027 (US$ Million)
    Figure 26. North America Rabies Vaccine Sales Market Share by Type (2016-2021)
    Figure 27. North America Rabies Vaccine Sales Market Share by Application (2016-2021)
    Figure 28. Asia-Pacific Rabies Vaccine Revenue 2016-2027 (US$ Million)
    Figure 29. Asia-Pacific Rabies Vaccine Sales Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Rabies Vaccine Revenue Market Share by Region (2016-2027)
    Figure 31. Asia-Pacific Rabies Vaccine Sales Market Share by Type (2016-2021)
    Figure 32. Asia-Pacific Rabies Vaccine Sales Market Share by Application (2016-2021)
    Figure 33. Europe Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 34. Europe Rabies Vaccine Sales Market Share by Country (2016-2027)
    Figure 35. Europe Rabies Vaccine Revenue Market Share by Country (2016-2027)
    Figure 36. Europe Rabies Vaccine Sales Market Share by Type (2016-2021)
    Figure 37. Europe Rabies Vaccine Sales Market Share by Application (2016-2021)
    Figure 38. Latin America Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 39. Latin America Rabies Vaccine Sales Market Share by Country (2016-2027)
    Figure 40. Latin America Rabies Vaccine Revenue Market Share by Country (2016-2021)
    Figure 41. Latin America Rabies Vaccine Sales Market Share by Type (2016-2021)
    Figure 42. Latin America Rabies Vaccine Sales Market Share by Application (2016-2021)
    Figure 43. Middle East and Africa Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 44. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2016-2027)
    Figure 46. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2016-2021)
    Figure 47. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2016-2021)
    Figure 48. Rabies Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Rabies Vaccine Raw Materials by Region in 2020
    Figure 50. Rabies Vaccine Distribution Channels
    Figure 51. Global Rabies Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 52. Global Rabies Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 53. Porter's Five Forces Analysis
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart